SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Initiates Ensysce Biosciences Coverage With Buy Rating, $2 Target

Valid market news retained in the public archive without immediate LiveCast distribution.

ENSC

Related stories